Curanex Pharmaceuticals：2025年季度报告

FORM10-Q (Mark One) ☒QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period endedJune 30,2025 ☐TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from __________ to ____________ Commission File No.001-42815 Curanex Pharmaceuticals Inc(Exact name of registrant as specified in its charter) (718)673-6078(Registrant’s telephone number, including area code) N/A(Former name, former address and former fiscal year, if changed since last report) Securities registered pursuant to Section 12(b) of the Act: Title of each classTrading Symbol(s)Name of exchange on which registeredCommon Stock, par value $0.0001 per shareCURXTheNasdaqCapital Market LLC Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities ExchangeAct of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) hasbeen subject to such filing requirements for the past 90 days. Yes☐No☒ Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant toRule 405 of Regulation S-T (§ 232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant wasrequired to submit such files).Yes☒No☐ Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reportingcompany, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reportingcompany,” and “emerging growth company” in Rule 12b-2 of the Exchange Act. ☐Accelerated filer☒Smaller reporting company☒Emerging growth company ☐Large accelerated filer☒Non-accelerated filer If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period forcomplying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.☐ Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes☐No☒ As of September 9, 2025, the registrant had27,750,000shares of common stock, par value $0.0001per share, outstanding. TABLE OF CONTENTS PagePART I – FINANCIAL INFORMATION4Item 1.Unaudited Financial Statements.4Item 2.Management’s Discussion and Analysis of Financial Condition and Results of Operations.21Item 3.Quantitative and Qualitative Disclosures about Market Risk.26Item 4.Controls and Procedures.27PART II – OTHER INFORMATION27Item 1.Legal Proceedings.27Item 1A.Risk Factors.27Item 2.Unregistered Sales of Equity Securities.27Item 3.Defaults Upon Senior Securities.28Item 4.Mine Safety Disclosures.28Item 5.Other Information.28Item 6.Exhibits.28SIGNATURES292 FORWARD-LOOKING STATEMENTS You should read the following discussion and analysis of our financial condition and results of operations in conjunction with our financialstatements and the accompanying notes thereto included elsewhere in this quarterly report on Form 10-Q (the “Quarterly Report”). This Quarterly Report contains forward-looking statements. Forward-looking statements are based upon our current assumptions,expectations and beliefs concerning future developments and their potential effect on our business. In some cases, you can identifyforward-lookingstatements by the following words:“may,”“will,”“could,”“would,”“should,”“expect,”“intend,”“plan,”“anticipate,” “believe,” “approximately,” “estimate,” “predict,” “project,” “potential,” “continue,” “ongoing,” or the negative of theseterms or other comparable terminology, although the absence of these words does not necessarily mean that a statement is not forward-looking. This information may involve known and unknown risks, uncertainties and other factors which may cause our actual results,performance or achievements to be materially different from the future results, performance or achievements expressed or implied by anyforward-looking statements. We cannot predict all of the risks and uncertainties. Accordingly, such information should not be regarded as representations that theresults or conditions described in such statements or that our objectives and plans will be achieved and we do not assume anyresponsibility for the accuracy or completeness of any of these forward-looking statements. These forward-looking statements includeinformation concerning possible or assumed future results of our operations,including statements about our business strategies; futurecash flows; financing plans; plans and objectives of management; any other statements regarding future acquisitions, future cash needs,future operations, business plans and future financial results, our ability to obtain or maintain patents or other appropriate protection forour intellect